Paper Details

  1. Home
  2. Paper Details

Safety and efficacy of coformulated efavirenz/emtricitabine/tenofovir single-tablet regimen in treatment-naive patients infected with HIV-1.

Author: De CastroNathalie, DelaugerreConstance, FlandrePhilippe, GallienSébastien, MolinaJean-Michel, NguyenNga

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study compared the clinical outcomes of two antiretroviral therapy (ART) regimens for HIV-1 patients: TDF/FTC+EFV and EFV/FTC/TDF. Results showed similar outcomes between the two groups, suggesting that the single-tablet regimen EFV/FTC/TDF could be approved for initial ART.
Paper Details　
Original Abstract of the Article :
Due to the differences between bioavailability of efavirenz (EFV) and tenofovir (TDF), the single-tablet regimen of EFV/emtricitabine (FTC)/TDF is not approved as initial antiretroviral therapy (ART) in Europe by the European Medical Agency. To compare clinical, immunological, and virological outcom...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/jmv.24023

データ提供：米国国立医学図書館（NLM）

Efavirenz/Emtricitabine/Tenofovir: A Safe and Effective Single-Tablet Regimen for HIV-1

The field of [HIV-1 Treatment] is constantly seeking to optimize [Antiretroviral Therapy (ART)] regimens. This study examines the safety and efficacy of a co-formulated single-tablet regimen of efavirenz/emtricitabine/tenofovir (EFV/FTC/TDF) in treatment-naive patients infected with HIV-1. The authors analyzed data from 231 patients who initiated either TDF/FTC+EFV or EFV/FTC/TDF between 2007 and 2010. The results demonstrate comparable clinical, immunological, and virological outcomes between the two groups, suggesting that the single-tablet regimen is as effective as the traditional combination therapy. The study also highlights a low rate of virological failure, further supporting the efficacy and safety of the single-tablet regimen.

Single-Tablet Regimen: An Effective and Convenient Treatment Option for HIV-1

This study provides evidence supporting the efficacy and safety of a co-formulated single-tablet regimen of EFV/FTC/TDF for treatment-naive patients infected with HIV-1. The research demonstrates comparable outcomes to traditional combination therapy, highlighting the potential of this single-tablet regimen to simplify treatment regimens and improve adherence.

HIV-1 Treatment: Empowering Patients with Convenient Options

This research offers encouraging news for patients living with HIV-1. The study's findings suggest that a single-tablet regimen of EFV/FTC/TDF can be as effective as traditional combination therapy, offering a more convenient and potentially more manageable treatment option.

Dr.Camel's Conclusion

Just as a desert oasis provides a welcome respite for weary travelers, a single-tablet regimen can offer a much-needed simplification to the complex journey of HIV-1 treatment. This research highlights the potential of EFV/FTC/TDF to improve adherence, reduce treatment burden, and ultimately enhance the quality of life for patients living with HIV-1.

Date :
  1. Date Completed 2015-08-07
  2. Date Revised 2022-03-18
Further Info :

Pubmed ID

25070158

DOI: Digital Object Identifier

10.1002/jmv.24023

Related Literature

Article Analysis
・Side Effects of emtricitabine and tenofovir
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.